Advanced in Choroid Plexus Papilloma

Ofelia Cruz

Barcelona, CT, ES 
Advanced in Choroid Plexus Papilloma
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

Ofelia Cruz practices in Barcelona, Spain. Ms. Cruz is rated as an Advanced expert by MediFind in the treatment of Choroid Plexus Papilloma. Her top areas of expertise are Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Posterior Fossa Tumor, and Choroid Plexus Papilloma.

Her clinical research consists of co-authoring 55 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Choroid Plexus Papilloma.

Gender
Female

Locations

Barcelona, CT, Spain
Other Locations
Sevilla, AN, Spain
Esplugues De Llobregat, CT 08950, Spain
Santiago De Compostela, GA 15782, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Enrollment Status: Terminated
Publish Date: May 31, 2022
Intervention Type: Drug
Study Drugs: Vinblastine+Nilotinib, Vinblastine
Study Phase: Phase 2
PHASE I-II STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA
PHASE I-II STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA
Enrollment Status: Completed
Publish Date: May 27, 2022
Intervention Type: Drug
Study Drugs: Nilotinib, Vinblastine
Study Phase: Phase 1
View 1 Less Clinical Trial

55 Total Publications

Very early-onset symptomatic CNS haemangioblastoma in Von Hippel-Lindau disease.
Very early-onset symptomatic CNS haemangioblastoma in Von Hippel-Lindau disease.
Journal: Journal of medical genetics
Published: October 29, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cruz's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile